Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Plexin B1 ELISA Kit (AC3029)
Cat.#: ASET-1618
Specifications
Description Human Plexin B1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Plexin B1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 25.84 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 400-6400 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1459 Human KALRN ELISA Kit (AC2870) Quantitative inquiry ASET-2203 Human Dopamine D2 Receptor ELISA Kit (AC3614) Quantitative inquiry ASET-2512 Rat Oxytocin ELISA Kit (AC3923) Quantitative inquiry ASET-2096 Human DDR2 ELISA Kit (AC3507) Quantitative inquiry ASET-1366 Rat Nestin ELISA Kit (AC2777) Quantitative inquiry ASET-2345 Human Urocortin 3 ELISA Kit (AC3756) Quantitative inquiry ASET-1008 Human KCNJ4 ELISA Kit (AC2419) Quantitative inquiry ASET-2425 Human DYRK1A ELISA Kit (AC3836) Quantitative inquiry ASET-1398 Human nNOS (neuronal) ELISA Kit (AC2809) Quantitative inquiry ASET-1813 Mouse LIF ELISA Kit (AC3224) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket